US Stock Movement | Zai Lab (ZLAB.US) Rises Over 8% as DLL3 ADC Launches Global Phase III Clinical Trial for First-Line SCLC
智通财经2026/09/02 14:01Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
智通财经APP has learned that on Wednesday, Zai Lab (ZLAB.US) rose over 8% to $27.44. In the news, on August 31, Zai Lab registered a global phase III clinical trial of ZL-1310 combined with PD-L1 antibody as a first-line treatment for ES-SCLC on Clinicaltrials.gov. This global phase III trial plans to enroll 530 first-line ES-SCLC patients and is expected to be preliminarily completed in June 2030.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Crypto prices
More
Bitcoin
BTC
$73,194.55
-2.09%
Ethereum
ETH
$2,024.61
-4.71%
Tether USDt
USDT
$0.9989
-0.00%
BNB
BNB
$673.51
-1.90%
USDC
USDC
$0.9997
-0.01%
XRP
XRP
$1.05
-3.55%
Solana
SOL
$82.34
-5.00%
TRON
TRX
$0.3175
+0.22%
Hyperliquid
HYPE
$70.91
-5.10%
Zcash
ZEC
$1,040.7
-11.20%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now